Antipyretic drugs :: Consumers survey results of 2022

Consumers survey results of 2022 in category

Cold and Flu / Antipyretic drugs

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.	4	Аспірин (Bayer)	38.46%	5

2.	7	Antiflu (Bayer)	30.77%	4.29

2.	12	Аскофен-Дарниця (Darnitsa)	30.77%	4.29

4.	18	Грипго (Gledpharm)	23.08%	3.57

4.	6	Парацетамол-Дарниця (Darnitsa)	23.08%	3.57

4.	15	Упсарин Упса (Bristol-Myers Squibb)	23.08%	3.57

7.	5	Антикатарал (Сперко Україна)	23.08%	2.86

7.	3	Німесил (Berlin-Chemie Menarini)	15.38%	2.86

9.	2	Анальгін-Дарниця (Darnitsa)	15.38%	2.14

9.	1	Фервекс (Bristol-Myers Squibb)	15.38%	2.14

11.	18	Хелпекс (Movi Health GmbH)	15.38%	1.43

12.	~	Терафлю (Novartis OTC)	7.69%	0.71

–.	11	Імет (Berlin-Chemie Menarini)	0.00%	0

–.	17	Аміцитрон (InterChem)	0.00%	0

–.	10	Анальгін (Pharmaceutical company “Zdorovya”)	0.00%	0

–.	8	Анальгін (Лубнифарм)	0.00%	0

–.		Аскопар (Pharmaceutical company “Zdorovya”)	0.00%	0

–.		Аскофен Л (Лубнифарм)	0.00%	0

–.		Грипаут (Wens Formulation)	0.00%	0

–.		Грипмакс (Unipharm, Inc)	0.00%	0

–.	16	Грипомед (Red star)	0.00%	0

–.	14	Гриппостад (Nizhpharm)	0.00%	0

–.	19	Ефералган (Bristol-Myers Squibb)	0.00%	0

–.	9	Колдрекс (GlaxoSmithKline)	0.00%	0

–.		Колдрін (Teva)	0.00%	0

–.		Колдфлю Екстра (Genom Biotech)	0.00%	0

–.	21	Комбігрип (ORGANOSYN)	0.00%	0

–.		Копацил (Arterium Corporation)	0.00%	0

–.		Кофальгін (Борщагівський ХФЗ)	0.00%	0

–.		Кофан (Bosnalijek)	0.00%	0

–.		Мілістан (Mili Healthcare)	0.00%	0

–.		Найз (Nimesulid)	0.00%	0

–.	21	Налгезін (KRKA)	0.00%	0

–.	20	Нурофєн (Reckitt Benckiser)	0.00%	0

–.		Німегезик (Alembic Chemical Works Company Ltd)	0.00%	0

–.	20	Панадол (GlaxoSmithKline)	0.00%	0

–.	10	Парацетамол (Arterium Corporation)	0.00%	0

–.	11	Парацетамол (Лубнифарм)	0.00%	0

–.		Парацетамол (сироп) (Борщагівський ХФЗ)	0.00%	0

–.		Пенталгін IC (InterChem)	0.00%	0

–.		Пенталгін-ICN (Фармстандарт-Лекарства)	0.00%	0

–.	16	Пенталгін-ФС (Фарма Старт)	0.00%	0

–.		Пиарон (Kusum Pharm)	0.00%	0

–.		Рапідол (Actavis)	0.00%	0

–.		Ринза (Johnson & Johnson)	0.00%	0

–.		Риніколд (Shreya Life Sciences)	0.00%	0

–.		Тринелл (Береш Фарма)	0.00%	0

–.		Фармадол (Farmak)	0.00%	0

–.	18	Фармацитрон (Pharmascience)	0.00%	0

–.	13	Флюколд-N (Nabros Pharma)	0.00%	0

–.		Цефекон Н (Nizhpharm)	0.00%	0

–.		Цитрамон Екстра (Darnitsa)	0.00%	0

–.		Цитрамон У (Лубнифарм)	0.00%	0

–.		Цитрамон-М (Red star)	0.00%	0

–.		Цитрамон-Ф (Фітофарм)	0.00%	0

–.		Цитропак-Дарниця (Darnitsa)	0.00%	0

The participant which took the 1st place in this rating is by opinion of Ukrainian consumers is the best choice in 2022, recommendation of consumers #1 in the category “Antipyretic drugs”.

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2022, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media. “Favorite of Success” medal

Participants of the contest (not excluding the leader) can also freely use this information in their news, press releases, reports and other PR-communications. However, it should be understood that the image of the contest awards, such like “Favorite of Success – 2022” medal, which is awarded to the winners at the annual awards ceremony, as well as official winner status &mdashl is the registered Trademarks, and their use requires permission, license.